Key Takeaways
- India needs a clear, statutory framework to regulate AI MedTech effectively
- The CDSCO's guidelines on software and AI use in medical devices are a step in the right direction
- Clinical validation and data safeguards are essential for the safe and effective use of AI in healthcare
- Bias, generalisability, and subgroup performance need to be addressed in AI algorithms to prevent adverse outcomes
- The regulatory framework for AI in healthcare is likely to continue to evolve
Introduction to AI MedTech Regulation
The integration of Artificial Intelligence (AI) in medicine and medical care is increasing globally, including in India. As AI begins to influence clinical decisions, its regulation has become an urgent patient-safety question. The Central Drugs Standard Control Organisation (CDSCO) has issued guidelines on software and AI use in medical devices, but India needs a clear, statutory framework that is law.
The national telemedicine consultation helpline e-Sanjeevani has integrated an AI-enabled clinical decision support system for healthcare providers. This is just one example of AI's increasing integration into medicine and medical care worldwide, and in India.
What is MedTech?
MedTech refers to instruments, apparatus, implants, software, or related devices used for diagnosis, prevention, monitoring, or treatment, whose primary action is not achieved through pharmacological, immunological, or metabolic means. Examples of MedTech include thermometers, glucometers, blood pressure apparatus, pacemakers, dialysis machines, and CT scanners.
Software is the set of instructions that makes a digital device work. A digital blood-pressure monitor, for example, uses embedded software to control cuff inflation, read pressure sensors, and calculate the final BP value. Within software are algorithms, which are step-by-step rules that convert inputs into outputs. AI (built on advanced algorithms such as machine learning and deep learning models) learns patterns from large amounts of data and uses them to make inferences.
Risk and Regulation
India currently regulates medical devices by stretching the Drugs and Cosmetics Act, 1940, which was intended mainly to penalise spurious drugs. The Medical Devices Rules, 2017, established the first dedicated rulebook, introducing four classes of devices - Class A for low risk, B for low-to-moderate risk, C for moderate-to-high risk, and D for high risk.
The manufacture of devices under classes A and B is generally handled by State licensing authorities, while the central authority regulates manufacture of devices under classes C and D as well as the import of all classes. In 2020, all devices meant for medical use, including software, came under the law.
The CDSCO's July 2026 guidance on software in medical devices brings software (including AI-enabled) used for a medical purpose into a clearer approval pathway. However, it explicitly says that it reflects existing practice and is not a new regulatory control.
Validation and Surveillance
Validation for AI-enabled devices is sought uniquely. The CDSCO seeks evidence of a sound clinical association between the output and the condition; whether the software technically produces the intended result, and whether it performs clinically in the population and setting (deployment) where it will be used.
Developers are expected to describe training, validation, and test datasets, including demographic, geographic, and clinical diversity when using AI. Models developed outside India may require justification and validation in representative Indian populations.
Bias, generalisability, and subgroup performance matter because even '95% accurate' means little without asking โ accurate at what, in whom, and against which reference standard? Approval is also a continuous process as algorithms can be retrained, software can be upgraded, while performance can drift.
Guidelines, not Law
India's AI regulation is outlined in policy papers of NITI Aayog, the Indian Council of Medical Research (ICMR), and the Ministry of Electronics and Information Technology. In 2018, NITI Aayog released the National Strategy for Artificial Intelligence, which named healthcare a priority.
ICMR then, in 2023, issued ethical guidelines for AI in healthcare, stressing the need for accountability, fairness, and patient autonomy. In November 2025, the Electronics & IT Ministry's AI Governance Guidelines chose not to propose a separate AI law, leaving each sector's regulator to act.
In February 2026, the Health Ministry launched the Strategy for Artificial Intelligence in Healthcare for India (SAHI), which addresses governance, data, validation, deployment, and monitoring of AI across healthcare.
- The United States Food and Drug Administration (FDA) has developed AI-specific lifecycle approaches, including predetermined change-control plans for defined future modifications.
- Europe combines medical-device regulation with the EU AI Act, which adds requirements for high-risk AI such as risk management, data quality, and human oversight.
Conclusion
In conclusion, India's AI MedTech regulation is evolving with guidelines and frameworks to ensure patient safety and effective integration of AI in healthcare. While the CDSCO's guidelines on software and AI use in medical devices are a step in the right direction, India needs a clear, statutory framework that is law to regulate AI MedTech effectively.
Expert Perspective
Experts in the field of AI and healthcare emphasize the need for clinical validation and data safeguards to ensure the safe and effective use of AI in healthcare. They also highlight the importance of addressing bias, generalisability, and subgroup performance in AI algorithms to prevent adverse outcomes.
Implications for Readers in India
The increasing use of AI in healthcare in India has significant implications for patients, healthcare providers, and regulators. Patients need to be aware of the potential benefits and risks of AI in healthcare, while healthcare providers need to ensure that they are using AI-enabled devices and software that are safe and effective. Regulators need to ensure that they are providing a clear and effective regulatory framework to govern the use of AI in healthcare.
What to Watch Next
As AI continues to evolve and become more integrated into healthcare, there are several key areas to watch. These include the development of new AI-enabled devices and software, the expansion of telemedicine services, and the increasing use of AI in medical research and development. Additionally, the regulatory framework for AI in healthcare is likely to continue to evolve, with a potential shift towards more stringent regulations and guidelines.
Frequently Asked Questions
What is AI MedTech?
AI MedTech refers to the use of Artificial Intelligence in medical devices and software, including those used for diagnosis, prevention, monitoring, or treatment.
How is AI MedTech regulated in India?
AI MedTech is regulated in India through a combination of guidelines and frameworks, including those issued by the CDSCO, NITI Aayog, and the Ministry of Electronics and Information Technology.
What are the key challenges in regulating AI MedTech?
The key challenges in regulating AI MedTech include ensuring patient safety, addressing bias and generalisability in AI algorithms, and providing a clear and effective regulatory framework.
